Financials
- Market Capitalization 14.31 M
- Employee 24
- Founded 2017
- CEO N/A
- Website www.passagebio.com
- Headquarter Delaware, United States
- FIGI BBG00NBK4XF9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.82
売上高対価格比率
25.52
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4720 | LEXX Lexaria Bioscience Corp. - Common Stock | 0.59 USD | -9.23% | +5.36% | -1.67% | -29.76% | 14.62 M USD | ||
| 4722 | TPST Tempest Therapeutics, Inc. - Common Stock | 0.98 USD | +1.03% | -8.41% | -24.03% | -59.00% | 14.51 M USD | ||
| 4729 | GTBP GT Biopharma, Inc. - Common Stock | 0.39 USD | -9.30% | -17.02% | -18.75% | -81.78% | 14.06 M USD | ||
| 4730 | QNCX Quince Therapeutics, Inc. - Common Stock | 17.25 USD | -1.65% | +2.19% | +1754.84% | +853.04% | 14.06 M USD |